Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Putting patients before patents.

Evans JP.

Genet Med. 2010 Apr;12(4):204-5. doi: 10.1097/GIM.0b013e3181d74c1c. No abstract available.

PMID:
20395743
2.

The fate and future of patents on human genes and genetic diagnostic methods.

Huys I, Matthijs G, Van Overwalle G.

Nat Rev Genet. 2012 May 18;13(6):441-8. doi: 10.1038/nrg3255.

PMID:
22596320
3.

Putting patients before patents.

Evans JP.

Genet Med. 2010 Apr;12(4 Suppl):S3-4. doi: 10.1097/GIM.0b013e3181d79ee1. No abstract available.

PMID:
20393309
4.

American College of Medical Genetics position statement on gene patents and accessibility of gene testing.

[No authors listed]

Genet Med. 1999 Jul-Aug;1(5):237. No abstract available.

PMID:
11256680
5.

The Human Genome Project and public perception: truth and consequences.

Pelias MZ, Markward NJ.

Emory Law J. 2000 Summer;49(3):837-58. No abstract available.

PMID:
12645564
6.

Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.

Aymé S, Matthijs G, Soini S; ESHG Working Party on Patenting and Licensing..

Eur J Hum Genet. 2008 May;16 Suppl 1:S10-9. doi: 10.1038/ejhg.2008.37.

7.

Patenting and licensing in genetic testing: ethical, legal, and social issues.

Soini S, Aymé S, Matthijs G; Public and Professional Policy Committee and Patenting and Licensing Committee..

Eur J Hum Genet. 2008 May;16 Suppl 1:S10-50. No abstract available.

PMID:
18557182
8.

Survey confirms fears about licensing of genetic tests.

Schissel A, Merz JF, Cho MK.

Nature. 1999 Nov 11;402(6758):118. No abstract available.

PMID:
10646997
9.

Introduction.

Matthijs G, Aymé S.

Eur J Hum Genet. 2008 May;16 Suppl 1:S1-2. doi: 10.1038/ejhg.2008.35. No abstract available.

10.

Gene patents--a pharmaceutical perspective.

Tribble JL.

Camb Q Healthc Ethics. 1998 Fall;7(4):429-32. No abstract available.

PMID:
9752585
11.

Patenting and licensing in genetic testing.

ESHG Working Party on Patenting and Licensing..

Eur J Hum Genet. 2008 Apr;16(4):405-11. doi: 10.1038/sj.ejhg.5201929. Erratum in: Eur J Hum Genet. 2008 Sep;16(9):1159. Aymé, S [removed]; Matthijs, G [removed]; Soini, S [removed].

12.

[No to patents for genetic diagnostics].

Lundsteen C.

Ugeskr Laeger. 2000 Jun 19;162(25):3620-1. Danish. No abstract available.

PMID:
11016292
13.

[Patents on genes--ethics going astray].

Vigen T.

Tidsskr Nor Laegeforen. 1999 Aug 20;119(19):2798. Norwegian. No abstract available.

PMID:
10494194
14.

Ethics and empiricism in the formation of professional guidelines.

Cho MK.

Am J Bioeth. 2014;14(3):1-2. doi: 10.1080/15265161.2014.890426. No abstract available.

PMID:
24592827
15.

[Are we threatened by misuse? Discreditation of medical genetics].

Goetz P, Foretová L, Macek M, Brdicka R, Jüttnerová V, Franková V, Horínová V, Payne J, Hach P.

Cas Lek Cesk. 2008;147(3):159-61. Czech. No abstract available.

PMID:
18401982
16.

Gene patents can be ethical.

McGee G.

Camb Q Healthc Ethics. 1998 Fall;7(4):417-21. No abstract available.

PMID:
9752582
17.

Wrong fixes for gene patents.

Dilenge T.

Nat Biotechnol. 2010 Dec;28(12):1242-3; author reply 1243. doi: 10.1038/nbt1210-1242. No abstract available.

PMID:
21139601
18.

Ethics and genetics: implications for CNS practice.

Horner SD.

Clin Nurse Spec. 2004 Sep-Oct;18(5):228-31. Review. No abstract available.

PMID:
15540062
19.

Issues in genetic testing.

Young DS, Leonard DG.

Clin Chem. 1999 Jun;45(6 Pt 1):915-26. No abstract available.

20.

Testing time for gene patents.

[No authors listed]

Nature. 2010 Apr 15;464(7291):957. doi: 10.1038/464957a. No abstract available.

PMID:
20393513
Items per page

Supplemental Content

Support Center